Micki Klearman
Director/Board Member at KEZAR LIFE SCIENCES, INC.
Net worth: - $ as of 2024-03-30
Profile
Micki Klearman is an Independent Director at Kezar Life Sciences, Inc. He previously worked at Genentech, Inc. as an Associate Group Medical Director-Immunology from 2007 to 2018.
He received his undergraduate degree from Stanford University and his doctorate from Washington University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
KEZAR LIFE SCIENCES INC
-.--% | 2023-07-23 | 0 ( -.--% ) | - $ | 2024-03-30 |
Micki Klearman active positions
| Companies | Position | Start |
|---|---|---|
| KEZAR LIFE SCIENCES, INC. | Director/Board Member | 2021-05-31 |
Former positions of Micki Klearman
| Companies | Position | End |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 2017-12-31 |
Training of Micki Klearman
| Stanford University | Undergraduate Degree |
| Washington University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| KEZAR LIFE SCIENCES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Micki Klearman
